Cooperative Agreement UC2AR086182
Award Date 9/19/25
Completion Date 7/31/30
Dollars Obligated $1.4M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is funded under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,570,904 award to the University of Pittsburgh aims to deepen the understanding of the key features associated with the overall experience of chronic low back pain (CLBP) in order to promote whole-person health. The project leverages the successful...
- The U.S. National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,643,228 Cooperative Agreement grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to Worcester Polytechnic Institute (WPI) to develop an Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment (IMPACT). The key objectives of this 2-year IMPACT project are to: 1) Initiate a clinical trial of Mindfulness-Based Stress Reduction (MBSR) for chronic low back pain...
- This $1,955,201.00 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) supports a research project titled "Biopsychosocial Determinants of Pediatric-Onset Chronic Musculoskeletal Pain" under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to enroll 600 adolescents and young adults, including 400 with chronic musculoskeletal pain and 200 without, to study the underlying biopsychosocial mechanisms driving...
- This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), is for $4,451,386 over the period from August 1, 2025 to July 31, 2028. The project aims to adapt and implement a Nurse Care Management (NCM) model to provide comprehensive care, including cognitive behavioral therapy (CBT) and a remotely delivered exercise program, for rural patients with chronic pain. The award will support...
- This $4,649,740.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to understand inter-individual differences in the clinical trajectory of chronic musculoskeletal pain (CMSKP). The research aims to develop network representations of patients' lived experience of pain and functional state using language models and home-based videos, and to analyze state transitions in...
- The University of Washington received a $1,024,374 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a 3-arm cluster randomized control trial. The project, titled "EQUITABLE PRIMARY CARE FOR PAIN CARE (EQUIP PC)", aims to adapt an Integrated Behavioral Health in Primary Care (IBH-PC) toolkit to improve equitable access to chronic pain care, train behavioral...
- This federal Project Grant award, totaling $2,884,007.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant was awarded to the University of California, San Diego (UCSD) to support research investigating mechanisms of intra- and inter-individual pain variability in patients with comorbid chronic low back pain (CLBP) and major depressive disorder (MDD). The research aims to generate individualized prediction...
- This Cooperative Agreement award, totaling $944,007, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025. The goal of the project is to partner with a national network of Community Health Centers (CHCs) to test a multi-component implementation support intervention. This intervention is designed to enable CHCs' systematic use of the Compass Rose care management application to...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $9,237,770 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Washington University to conduct the "IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain After Surgery" research project. The goal is to gain integrated mechanistic insights into peripheral and central biological processes that contribute to chronic postsurgical pain...
- This $264,995 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the development and evaluation of an adaptive psychological intervention to improve pain management and reduce opioid use following a musculoskeletal injury. The proposed study aims to optimize and examine the feasibility and acceptability of this intervention, which includes a low-intensity computerized brief intervention followed by a...